Kyverna Therapeutics, Inc. (KYTX) Free cash flow 2023–2025
Kyverna Therapeutics, Inc. (KYTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$153.7MFY2025 · since FY2023: -$53.0M → -$153.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$153.7M | -32.0% |
| FY2024 | -$116.5M | -119.6% |
| FY2023 | -$53.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More KYTX financial trends
KYTX RevenueKYTX Net incomeKYTX Net marginKYTX Gross profitKYTX Gross marginKYTX Operating incomeKYTX Operating marginKYTX Operating cash flowKYTX Capital expendituresKYTX Return on equityKYTX Stock buybacksKYTX Dividends paidKYTX Total assetsKYTX Total liabilitiesKYTX Shareholders’ equityKYTX overview →